Australian Radiation Protection and Nuclear Safety Act 1998
Australian Radiation Protection and Nuclear Safety Regulations 1999
Declaration of Exemption
I, Carl-Magnus Larsson, Chief Executive Officer of ARPANSA, acting under the Australian Radiation Protection and Nuclear Safety Regulations 1999 (the Regulations), hereby conclude that siting a new controlled facility, namely:
The particle accelerator with beam energy of more than 1 MeV, located at the ARPANSA site, 619 Lower Plenty Road, Yallambie VIC,
which is to be controlled by ARPANSA Medical Radiation Services (MRS), will not pose an unacceptable potential hazard to the health and safety of people or the environment and, therefore, satisfies the requirements of sub-regulation 37(1) of the Regulations.
The particle accelerator, specifically a linear accelerator, will be of a typical design producing electrons of up to 20 MeV. It will be operated as a national facility for calibration of radiotherapy linear accelerators in Australia and overseas. The organisation has been operating linear accelerators for the last 20 years on the campus for similar purposes.
Consequently, I exempt MRS from the need to obtain authorisation to prepare a site for the particle accelerator for the purposes of section 30(1)(a) of the Australian Radiation Protection and Nuclear Safety Act 1998, as it will be housed in existing premises.
This Exemption will expire when the facility licence for construction is issued.
Carl-Magnus Larsson
CEO of ARPANSA
3rd January 2018
Overview
The Australian Radiation Protection and Nuclear Safety Act 1998, enacted by the Commonwealth Parliament, was introduced to provide a robust framework for the protection of the public and the environment from the potential hazards of ionising radiation and nuclear substances. This legislation aims to regulate the use, storage, and transport of radioactive materials and facilities that emit ionising radiation, ensuring safety standards are met across Australia. One of the policy objectives of the Act is to facilitate safe and beneficial uses of radiation and nuclear technology, while also providing mechanisms for effective regulatory oversight. The Act, in conjunction with the Australian Radiation Protection and Nuclear Safety Regulations 1999, seeks to minimise risks associated with radiation exposure through stringent controls and licensing requirements. The declaration of exemption by the Chief Executive Officer of the Australian Radiation Protection and Nuclear Safety Authority (ARPANSA) for a new particle accelerator, as presented in the document, exemplifies the practical application of these legislative provisions to ensure that specific facilities comply with safety standards without unnecessary administrative burden.
Scope and Application
The Australian Radiation Protection and Nuclear Safety Act 1998 (ARPANSA Act) provides a comprehensive framework for the regulation of radiation protection and nuclear safety in Australia, applying to entities and persons involved in activities that may expose humans or the environment to ionising radiation. The Act applies broadly to the siting, design, construction, operation, and decommissioning of facilities and equipment that generate or use radioactive materials, including medical, industrial, and research applications. The Australian Radiation Protection and Nuclear Safety Regulations 1999 (Regulations) further detail specific requirements and standards that must be adhered to, including the exemption of certain facilities from authorisation processes under particular conditions. In this case, the Chief Executive Officer of ARPANSA has determined that a new particle accelerator, to be situated on the ARPANSA campus in Yallambie, Victoria, does not pose an unacceptable risk to health and safety or the environment. This determination exempts ARPANSA Medical Radiation Services from the need to obtain authorisation for the site preparation under section 30(1)(a) of the ARPANSA Act. The exemption is contingent upon the facility being housed in existing premises and will remain in effect until a facility licence for construction is issued. This exemption is narrowly tailored and subject to the specific conditions outlined in the declaration, ensuring that safety standards are maintained while facilitating necessary scientific and medical advancements.
Key Provisions
The Australian Radiation Protection and Nuclear Safety Act 1998 (the Act) and its accompanying Regulations govern the safe use and control of radiation and nuclear substances in Australia. Section 30(1)(a) of the Act requires an entity to obtain authorisation before preparing a site for a controlled facility, which includes a particle accelerator with a beam energy exceeding 1 MeV. However, under sub-regulation 37(1) of the Australian Radiation Protection and Nuclear Safety Regulations 1999, an exemption can be granted if the facility does not pose an unacceptable potential hazard to health and safety or the environment. In this instance, the Chief Executive Officer of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Carl-Magnus Larsson, has declared an exemption for ARPANSA Medical Radiation Services (MRS) from obtaining such authorisation for the siting of a particle accelerator at the ARPANSA site in Yallambie, Victoria.
The exemption is based on a detailed assessment that the particle accelerator, a linear accelerator designed to produce electrons up to 20 MeV, will not create an unacceptable hazard. The exemption takes into account MRS's extensive experience in operating similar facilities on the campus over the past 20 years. Furthermore, the particle accelerator will be used as a national facility for the calibration of radiotherapy linear accelerators in Australia and overseas. By concluding that the facility meets the safety requirements, Carl-Magnus Larsson has determined that MRS is exempt from the authorisation process required by section 30(1)(a) of the Act for preparing the site for this specific facility.
Under the Act and Regulations, MRS must adhere to certain obligations and requirements to ensure the safe operation of the particle accelerator. These include complying with all applicable safety standards, maintaining appropriate records, and ensuring that the facility is operated in a manner that minimises any potential risk to health and safety and the environment. MRS must also ensure that the facility is adequately supervised and that personnel are appropriately trained and qualified to handle the equipment and radiation safely. Additionally, MRS is required to report any incidents or accidents involving the facility to ARPANSA promptly.
Failure to comply with the requirements of the Act and Regulations can result in serious consequences. The Act outlines various offences and penalties for breaches, which can include fines and imprisonment. For example, section 44 of the Act provides for a maximum penalty of $1.65 million for a corporation and $330,000 for an individual for serious breaches related to radiation protection and nuclear safety. In addition to criminal penalties, breaches can also lead to civil consequences, such as the imposition of administrative penalties or the revocation of authorisations and licences. It is essential that MRS adheres strictly to the legislative requirements to avoid these serious repercussions.